Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) — The “France Diabetes Device Market Forecast Report by Types, Distribution Channel and Company Analysis 2024-2032” report has been added to ResearchAndMarkets.com’s offering.
The France Diabetes Device market is expected to reach US$ 946.9 million in 2023 to US$ 1.78 billion by 2032, with a CAGR of 7.3% from 2024 to 2032. The market for diabetes care devices in France is also being driven by factors such as the increasing incidence of diabetes and obesity, expanding awareness of diabetic care, healthcare spending, and technical improvements. The major participants in the France Diabetes Device market includes BD, Medtronic, Tandem Diabetes Care, Novo Nordisk A/S, Roche, Abbott Laboratories, Eli Lilly, Ypsomed AG, Dexcom Inc.
France’s Diabetes Population is Growing, Increasing the Market for Diabetes Devices in France
Among the 59 countries that make up the IDF-EUR area is France. Furthermore, 538 million people globally and 62 million people in the Europe Region were predicted to have diabetes in 2022; by 2045, this figure is predicted to rise to 69 million. As per a report conducted by the European Commission, one in ten individuals in France have diabetes, making it the country with the greatest prevalence of chronic diabetes.
France has a high rate of diabetes, despite the fact that the regulations’ goal of 80% compliance with recommended medical consultations isn’t always reached. New approaches that emphasize patient and physician education and information are required to reduce the burden of complications and hospitalizations related to diabetes in order to encourage proactive therapy adjustment and diminish therapeutic inertia.
According to a 2022 article titled “Epidemiology and Health Impact of Diabetes in France,” after a 5-year period, patients with diabetes type-1 reported more diabetes-related difficulties than type-2 (52.2 vs. 34.7%). Additionally, across a two-year period, patients with diabetes type-1 had a higher frequency of diabetes-related admissions (29.8% vs. 16.9%) than patients with diabetes type-2.
Growing Health Concerns
The management of diabetes is becoming more widely known, which has a big impact on patient behavior and treatment decisions. individuals are increasingly inclined to look for improved diabetes management strategies as more individuals become aware of the dangers and difficulties connected to the disease.
Information regarding effective monitoring and treatment choices is being disseminated through community initiatives, educational programs, and public health campaigns. This increased awareness stimulates demand for cutting-edge diabetes solutions and gadgets as well as healthy lifestyle adoption. Healthcare providers are responding to patients’ pro-active caregiving with creative solutions that improve management and overall results.
Types – Industry is divided into 4 viewpoints:
1. Self-Monitoring Devices
2. Continuous Glucose-Monitoring Devices
3. Insulin Pumps
4. Insulin Pens
Distribution Channel – Industry is divided into 4 viewpoints:
1. Hospital Pharmacies
2. Retail Pharmacies
3. Diabetes Clinics/Centers
4. Online Pharmacies
Company Analysis
1. BD
2. Medtronic
3. Tandem Diabetes Care
4. Novo Nordisk A/S
5. Roche
6. Abbott Laboratories
7. Eli Lilly
8. Ypsomed AG
9. Dexcom Inc.
All companies have been covered with 5 viewpoints:
1. Overviews
2. Key Persons
3. Recent Developments & Strategies
4. Product Portfolio & Product Launch Over the Last Year
5. Revenue
Key Questions Answered in Report:
1. How big is the France Diabetes Device industry?
2. What is the France Diabetes Device industry growth rate?
3. Who are the key players in France Diabetes Device industry?
4. What are the factors driving the France Diabetes Device industry?
5. Which Region held the largest market share in the France Diabetes Device industry?
6. What segments are covered in the France Diabetes Device Market report?
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023-2032 |
| Estimated Market Value (USD) in 2023 | $946.9 Million |
| Forecasted Market Value (USD) by 2032 | $1,784.6 Million |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | France |
For more information about this report visit https://www.researchandmarkets.com/r/8auu9g
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- French Diabetes Device Market
